ライフサイエンスコーパス: Cushing's syndrome

1 13 of 63 tumors (35% of adenomas with overt Cushing's syndrome).

2 for the treatment of selected patients with Cushing's syndrome.

3 nd treatment of endogenous hypercortisolism--Cushing's syndrome.

4 l focus on new diagnostics and treatments of Cushing's syndrome.

5 the fat distribution changes associated with Cushing's syndrome.

6 struction in multiple myeloma and endogenous Cushing's syndrome.

7 in a phase 2 clinical study in patients with Cushing's syndrome.

8 tumors autonomously producing cortisol cause Cushing's syndrome.

9 perplasia is a rare cause of primary adrenal Cushing's syndrome.

10 promising therapeutics for the treatment of Cushing's syndrome.

11 r it may be identified during evaluation for Cushing's syndrome.

12 YP11B1 inhibition is a promising therapy for Cushing's syndrome.

13 ring conditions of circulating excess, e.g., Cushing's syndrome.

14 has been implicated based on parallels with Cushing's syndrome.

15 s (ACA), and hyperplasia (ACH) involved with Cushing's syndrome.

16 ons and reduce the mortality associated with Cushing's syndrome.

17 one suppression test were done to screen for Cushing's syndrome.

18 tic subunit of PKA in tumors associated with Cushing's syndrome, a kidney disorder leading to excessi

19 KA fusion protein were found to be linked to Cushing's syndrome and FL-HCC, respectively.

20 In humans, Cushing's syndrome and long-term prescription corticoste

21 olaemic patients, both those with endogenous Cushing's syndrome and, much more frequently, those rece

22 cially if associated with bone metastases or Cushing's syndrome), and the extent of liver metastases

23 leptin resistance occurs in aging, obesity, Cushing's syndrome, and acquired lipodystrophy, and prel

24 n patients with macronodular hyperplasia and Cushing's syndrome appears to be regulated by corticotro

25 coids, such as major depressive disorder and Cushing's syndrome, are reported to have smaller hippoca

26 They die before 9 weeks of severe Cushing's syndrome arising from pituitary intermediate l

27 type 2 diabetes, and dyslipidemia) resembles Cushing's Syndrome, but without elevated circulating glu

28 euroendocrine or metabolic disorders such as Cushing's syndrome (CS).

29 In the Cushing's syndrome disorder, we find that the L205R muta

30 hyperexcitability of the HPA axis, including Cushing's syndrome, epilepsy, and major depression.

31 one concentration, and a pituitary source of Cushing's syndrome, from 57 sites across 19 countries.

32 Hypertension in patients with Cushing's syndrome has a multifactorial pathogenesis and

33 th CAH, and adults can experience iatrogenic Cushing's syndrome, hyperandrogenism, infertility, or th

34 ticoids results in diverse manifestations of Cushing's syndrome, including debilitating morbidities a

35 Cushing's syndrome is a serious endocrine disease caused

36 Corticotropin-independent Cushing's syndrome is caused by tumors or hyperplasia of

37 Endogenous Cushing's syndrome is caused either by excess ACTH secre

38 Hypercortisolaemia (Cushing's syndrome) is characterised by abdominal fat ac

39 al development of bone metastases or ectopic Cushing's syndrome markedly decreased survival rate.

40 of metastases; and the occurrence of ectopic Cushing's syndrome or another PET syndrome.

41 mph node, liver, or bone metastases; ectopic Cushing's syndrome; or higher gastrin levels.

42 Cushing's syndrome results from lengthy and inappropriat

43 nes, resulting from either drug treatment or Cushing's syndrome, results in insulin resistance, centr

44 eral adenomas (37%) from patients with overt Cushing's syndrome; these mutations were not detectable

45 t with symptoms of hormone excess, including Cushing's syndrome, virilization, feminization, or--less

46 No other signs of Cushing's syndrome were observed, and plasma cortisol va

47 Age, weight, and diagnostic categories of Cushing's syndrome were similar between the two groups a

48 postoperative complications in patients with Cushing's syndrome who underwent bilateral adrenalectomy

49 ients undergoing bilateral adrenalectomy for Cushing's syndrome without other contraindications for u

50 Cushing's syndrome without virilization was uncommon (5.